| 1.6 |
6.2 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 1.4 |
7.1 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 1.2 |
1.2 |
GO:0002605 |
negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
| 1.2 |
7.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 1.2 |
3.6 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.2 |
5.9 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 1.1 |
3.4 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 1.0 |
3.1 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.0 |
2.0 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.0 |
6.7 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.9 |
2.8 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.9 |
5.5 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.9 |
4.4 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.8 |
2.5 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.8 |
2.5 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.8 |
3.2 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.8 |
3.2 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.8 |
0.8 |
GO:1904397 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.8 |
2.3 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.8 |
3.8 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.8 |
5.3 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.8 |
0.8 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.7 |
2.2 |
GO:0060532 |
bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.7 |
5.9 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.7 |
2.2 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.7 |
3.5 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.7 |
2.8 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.7 |
1.4 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.7 |
2.1 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.7 |
1.4 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.7 |
0.7 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.7 |
2.0 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.7 |
2.0 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.7 |
2.7 |
GO:0036483 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.6 |
1.9 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.6 |
2.5 |
GO:0003350 |
pulmonary myocardium development(GO:0003350) |
| 0.6 |
2.5 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.6 |
3.7 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.6 |
4.8 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.6 |
2.9 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.6 |
2.9 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.6 |
6.9 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.6 |
2.9 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.6 |
3.4 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.6 |
1.7 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.5 |
1.6 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 |
2.2 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.5 |
6.6 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.5 |
2.2 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.5 |
1.6 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.5 |
1.6 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.5 |
0.5 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.5 |
1.6 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.5 |
2.1 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.5 |
0.5 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 |
2.1 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.5 |
3.6 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.5 |
1.5 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.5 |
1.5 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.5 |
1.5 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.5 |
1.5 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.5 |
4.5 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.5 |
3.0 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.5 |
6.4 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.5 |
1.5 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.5 |
1.5 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.5 |
1.0 |
GO:0001743 |
optic placode formation(GO:0001743) |
| 0.5 |
2.9 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.5 |
1.9 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 0.5 |
2.4 |
GO:0071400 |
cellular response to oleic acid(GO:0071400) |
| 0.5 |
1.9 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.5 |
0.5 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.5 |
0.5 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.5 |
1.8 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.5 |
1.8 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.4 |
3.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.4 |
4.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 |
1.3 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.4 |
1.7 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.4 |
3.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.4 |
1.7 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.4 |
2.1 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.4 |
0.4 |
GO:1902373 |
negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.4 |
3.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
0.4 |
GO:0071888 |
macrophage apoptotic process(GO:0071888) |
| 0.4 |
2.5 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.4 |
1.7 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.4 |
1.7 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.4 |
1.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.4 |
2.8 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.4 |
2.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.4 |
0.4 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.4 |
1.2 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.4 |
3.1 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.4 |
1.6 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 |
1.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.4 |
0.4 |
GO:0048016 |
inositol phosphate-mediated signaling(GO:0048016) |
| 0.4 |
2.7 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.4 |
1.5 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.4 |
1.5 |
GO:1903979 |
negative regulation of microglial cell activation(GO:1903979) |
| 0.4 |
2.7 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.4 |
2.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.4 |
1.5 |
GO:0009183 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.4 |
1.1 |
GO:0030806 |
negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.4 |
2.6 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.4 |
1.5 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.4 |
1.8 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.4 |
2.9 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.4 |
1.1 |
GO:0034136 |
negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
| 0.4 |
2.1 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.4 |
3.5 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.4 |
1.8 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.4 |
0.7 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.3 |
2.1 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 |
1.7 |
GO:1902728 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.3 |
2.1 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
1.0 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.3 |
1.0 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.3 |
0.7 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 |
1.4 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
1.4 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.3 |
2.7 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 |
0.3 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
| 0.3 |
1.3 |
GO:0035669 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 |
1.0 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.3 |
1.0 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 |
0.3 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.3 |
1.3 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
2.6 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 |
0.7 |
GO:0033081 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.3 |
1.3 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.3 |
0.9 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 0.3 |
2.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.3 |
0.3 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.3 |
3.1 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 |
0.9 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 |
1.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 |
5.6 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.3 |
1.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.3 |
3.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.3 |
2.1 |
GO:1902903 |
regulation of fibril organization(GO:1902903) |
| 0.3 |
1.8 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.3 |
0.9 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.3 |
4.8 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.3 |
0.6 |
GO:0003229 |
ventricular cardiac muscle tissue development(GO:0003229) ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.3 |
6.9 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.3 |
0.3 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.3 |
0.9 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.3 |
1.8 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 |
0.9 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.3 |
0.9 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.3 |
5.9 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.3 |
1.8 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.3 |
2.4 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.3 |
2.3 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.3 |
0.3 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.3 |
0.9 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 |
9.3 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.3 |
2.6 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.3 |
2.3 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 |
2.0 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.3 |
1.1 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 |
1.1 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.3 |
4.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 |
0.9 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.3 |
0.8 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.3 |
1.7 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 |
5.4 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 |
0.8 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.3 |
1.1 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.3 |
2.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
0.3 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.3 |
3.0 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.3 |
1.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
0.8 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.3 |
0.3 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.3 |
0.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
0.8 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.3 |
1.1 |
GO:0060849 |
radial pattern formation(GO:0009956) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.3 |
0.5 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.3 |
1.6 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.3 |
0.8 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 |
5.5 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 |
0.8 |
GO:0048369 |
lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
| 0.3 |
1.1 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.3 |
0.8 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 |
0.5 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.3 |
0.3 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.3 |
0.8 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.3 |
0.8 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.3 |
0.8 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.3 |
1.0 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.3 |
1.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.3 |
0.8 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.3 |
2.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 |
0.8 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.2 |
1.2 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.2 |
1.0 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.2 |
1.2 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 |
0.7 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.2 |
0.5 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.2 |
1.0 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.2 |
0.5 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.2 |
2.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.2 |
0.2 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.2 |
0.2 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.2 |
0.7 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
3.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
4.7 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 |
0.2 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.2 |
1.2 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.2 |
0.7 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 |
0.2 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.2 |
4.6 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
1.8 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.2 |
0.7 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.2 |
0.2 |
GO:0055123 |
digestive system development(GO:0055123) |
| 0.2 |
1.6 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
1.8 |
GO:0045007 |
depurination(GO:0045007) |
| 0.2 |
0.9 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.2 |
1.8 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
0.2 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.2 |
2.2 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
1.1 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
1.3 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.2 |
0.7 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.2 |
0.7 |
GO:0003220 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.2 |
0.7 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.2 |
0.7 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.2 |
0.4 |
GO:0001825 |
blastocyst development(GO:0001824) blastocyst formation(GO:0001825) |
| 0.2 |
1.6 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.2 |
1.1 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
1.5 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.2 |
1.3 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.2 |
0.9 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.2 |
0.9 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.2 |
0.4 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 |
3.5 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
0.4 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.2 |
1.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
0.6 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
2.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
0.6 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
1.9 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.2 |
0.8 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 |
2.7 |
GO:0061549 |
sympathetic ganglion development(GO:0061549) |
| 0.2 |
0.8 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.2 |
0.6 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 |
4.2 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.2 |
1.5 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.2 |
1.4 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.2 |
0.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 |
0.2 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
0.8 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.2 |
0.2 |
GO:1901983 |
regulation of protein acetylation(GO:1901983) |
| 0.2 |
0.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
1.4 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.2 |
0.8 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 |
2.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
0.8 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.2 |
0.6 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.2 |
0.2 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.2 |
0.6 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 |
0.4 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 0.2 |
0.6 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.6 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.2 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.2 |
0.6 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.2 |
1.9 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.2 |
0.6 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.2 |
0.2 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 |
1.0 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 |
1.0 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
0.4 |
GO:0034971 |
histone H3-R17 methylation(GO:0034971) |
| 0.2 |
1.5 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.2 |
0.8 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.2 |
1.5 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.2 |
0.9 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 |
0.6 |
GO:0072684 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.2 |
2.8 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.2 |
2.3 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.2 |
0.6 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.2 |
0.9 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 |
0.4 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
3.2 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
0.2 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.2 |
0.6 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.2 |
0.7 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.2 |
1.3 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
0.6 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 |
0.7 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 |
0.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
3.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
0.4 |
GO:0031659 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.2 |
0.9 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 |
0.2 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
0.4 |
GO:0060947 |
cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 0.2 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
0.5 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.2 |
1.8 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 |
0.2 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.2 |
1.4 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 |
4.1 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 |
1.4 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.2 |
0.7 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 |
0.5 |
GO:0018194 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.2 |
1.4 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.2 |
3.0 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.2 |
1.6 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
1.4 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.2 |
0.4 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.2 |
1.8 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 |
0.5 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of pancreatic juice secretion(GO:0090187) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.2 |
1.2 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
0.2 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
| 0.2 |
0.2 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.2 |
3.0 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
1.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
0.2 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.2 |
3.6 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.3 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.2 |
2.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.2 |
0.2 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.2 |
1.0 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 |
12.3 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.2 |
0.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.2 |
6.3 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.5 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.2 |
0.5 |
GO:0071812 |
circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.2 |
0.3 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.2 |
1.4 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
0.2 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 |
0.8 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.2 |
2.5 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 |
0.8 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.5 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.2 |
0.2 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.2 |
0.5 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.2 |
0.3 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
0.5 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.2 |
0.7 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 |
2.5 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
0.7 |
GO:0030262 |
cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.2 |
4.9 |
GO:0035729 |
cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.2 |
3.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
1.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
1.0 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.5 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.2 |
0.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 |
2.6 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.2 |
1.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 |
0.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 |
0.9 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
0.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
2.0 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
1.4 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.2 |
1.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
0.2 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 |
0.5 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
4.3 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.2 |
0.9 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.2 |
1.4 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
0.5 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 |
0.3 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.2 |
1.4 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.2 |
8.1 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.2 |
0.9 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.2 |
0.3 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
1.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 |
0.5 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.2 |
0.5 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.6 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.1 |
GO:0032792 |
negative regulation of triglyceride biosynthetic process(GO:0010868) negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.9 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
2.2 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
2.1 |
GO:0042634 |
regulation of hair cycle(GO:0042634) |
| 0.1 |
2.2 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.3 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 0.1 |
0.4 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0060067 |
cervix development(GO:0060067) |
| 0.1 |
0.6 |
GO:0043328 |
protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 |
1.2 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.1 |
0.3 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
0.7 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
3.7 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.6 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 |
0.3 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.3 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.1 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.1 |
0.7 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.4 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.1 |
0.1 |
GO:0060126 |
somatotropin secreting cell differentiation(GO:0060126) |
| 0.1 |
0.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
1.3 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.6 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
2.1 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
0.4 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.1 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.1 |
0.4 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 |
5.3 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
1.0 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.7 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
0.1 |
GO:0042700 |
luteinizing hormone signaling pathway(GO:0042700) |
| 0.1 |
0.1 |
GO:1903626 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.1 |
1.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
1.2 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.1 |
0.3 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.1 |
0.5 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.1 |
2.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.5 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.1 |
10.7 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.3 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.1 |
1.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
1.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.1 |
GO:0090296 |
regulation of mitochondrial DNA replication(GO:0090296) |
| 0.1 |
0.3 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
0.1 |
GO:0046320 |
regulation of fatty acid oxidation(GO:0046320) |
| 0.1 |
0.3 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.1 |
2.0 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.1 |
2.4 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.4 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.1 |
0.1 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
0.3 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
2.2 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
1.2 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.1 |
1.3 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.1 |
0.8 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.5 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.1 |
0.4 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.1 |
0.5 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 |
0.5 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
1.4 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
0.7 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.9 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
1.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.4 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 |
0.9 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
2.6 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 |
1.0 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.1 |
2.5 |
GO:0001682 |
tRNA 5'-leader removal(GO:0001682) |
| 0.1 |
1.0 |
GO:0039692 |
single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.1 |
0.3 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.1 |
0.4 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
1.8 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.3 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) |
| 0.1 |
1.4 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.1 |
5.3 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 |
2.5 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.1 |
1.5 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
2.5 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.1 |
0.2 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.1 |
0.9 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
1.2 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 |
0.7 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
3.1 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.1 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
1.9 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.1 |
0.7 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.7 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 |
4.4 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.6 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 |
0.2 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
1.7 |
GO:0070129 |
regulation of mitochondrial translation(GO:0070129) |
| 0.1 |
0.4 |
GO:0070681 |
glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 |
0.7 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.1 |
2.3 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.1 |
1.2 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
1.7 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.2 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.1 |
0.6 |
GO:0045990 |
carbon catabolite regulation of transcription(GO:0045990) |
| 0.1 |
0.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
2.2 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
1.7 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.6 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.1 |
0.5 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 |
0.9 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
1.6 |
GO:0006402 |
mRNA catabolic process(GO:0006402) |
| 0.1 |
0.5 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 |
2.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
2.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 |
0.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.1 |
1.9 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.9 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
1.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.9 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.7 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.1 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 |
0.7 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 0.1 |
0.2 |
GO:0097534 |
lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.1 |
0.1 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.1 |
0.1 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 |
1.8 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.3 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
1.8 |
GO:0070586 |
cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 |
1.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.2 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.1 |
0.2 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.5 |
GO:1904744 |
regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 |
1.3 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.2 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.1 |
0.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
2.5 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) |
| 0.1 |
3.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
1.4 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.2 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 |
0.3 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.2 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.1 |
0.4 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
0.2 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.1 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
1.6 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.1 |
0.1 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.1 |
0.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.8 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.7 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.1 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.1 |
0.3 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.1 |
0.1 |
GO:0044843 |
cell cycle G1/S phase transition(GO:0044843) |
| 0.1 |
0.5 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.1 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.2 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.1 |
0.8 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.8 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.8 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 |
1.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.5 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.1 |
0.6 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.3 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.3 |
GO:0048075 |
positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
0.9 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 |
0.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.7 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.1 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.2 |
GO:2000561 |
CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.1 |
0.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.3 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.1 |
0.7 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 |
0.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.8 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
1.0 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 |
0.5 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
1.1 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.9 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.2 |
GO:2000307 |
activation of MAPK activity involved in innate immune response(GO:0035419) tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) positive regulation of thymocyte migration(GO:2000412) |
| 0.1 |
0.3 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
0.2 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.1 |
0.2 |
GO:0051563 |
smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.1 |
1.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.5 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.1 |
0.4 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.1 |
0.1 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.1 |
0.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
4.0 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.4 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.4 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.1 |
0.6 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.4 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 |
0.5 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.1 |
3.4 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.8 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.9 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.5 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.4 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.7 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.1 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
0.8 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.5 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 |
0.4 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
1.8 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.1 |
0.1 |
GO:0098706 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 |
2.9 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.8 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 |
0.3 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 |
0.5 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.3 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
1.3 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.1 |
0.1 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.1 |
0.9 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.1 |
0.7 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
1.7 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
0.1 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.3 |
GO:0061430 |
bone trabecula morphogenesis(GO:0061430) |
| 0.1 |
0.2 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
0.2 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.2 |
GO:1904385 |
angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) |
| 0.1 |
0.3 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.3 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.3 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.1 |
0.2 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.1 |
0.3 |
GO:0072666 |
establishment of protein localization to vacuole(GO:0072666) |
| 0.1 |
0.2 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 |
0.5 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.1 |
0.5 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 |
0.4 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.8 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.7 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.1 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.4 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
1.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.9 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.3 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.1 |
3.9 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.1 |
1.9 |
GO:0036336 |
dendritic cell migration(GO:0036336) |
| 0.1 |
0.3 |
GO:1904995 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
0.2 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
1.1 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.1 |
0.2 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.1 |
0.4 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.1 |
0.2 |
GO:2000612 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) metanephric nephron tubule formation(GO:0072289) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 |
0.3 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.1 |
0.2 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
1.0 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.9 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
1.3 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.1 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 |
0.2 |
GO:2001178 |
mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 |
1.3 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.1 |
0.4 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 |
2.2 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
0.2 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.1 |
0.2 |
GO:0035546 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
| 0.1 |
1.7 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.1 |
0.3 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.1 |
0.5 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.1 |
0.8 |
GO:0009896 |
positive regulation of catabolic process(GO:0009896) |
| 0.1 |
1.4 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.2 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
0.1 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.2 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
1.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.1 |
0.2 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
0.5 |
GO:0006226 |
dUMP biosynthetic process(GO:0006226) |
| 0.1 |
0.1 |
GO:0090188 |
regulation of pancreatic juice secretion(GO:0090186) negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.1 |
0.4 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.1 |
GO:0031126 |
snoRNA 3'-end processing(GO:0031126) |
| 0.1 |
0.9 |
GO:0045453 |
bone resorption(GO:0045453) |
| 0.1 |
0.2 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 |
0.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
1.1 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.1 |
0.8 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.3 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
1.9 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 |
0.1 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.1 |
0.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.5 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.9 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.1 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.3 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.4 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.1 |
0.6 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.2 |
GO:0019516 |
lactate oxidation(GO:0019516) |
| 0.1 |
0.4 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 |
6.6 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.1 |
0.6 |
GO:0061365 |
positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.1 |
0.8 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 |
0.8 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.2 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
0.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
4.3 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.5 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.1 |
0.3 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.3 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
1.0 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.9 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.2 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.1 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.1 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 |
0.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.2 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.1 |
0.2 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.1 |
0.3 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.1 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.6 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
0.2 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
0.1 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.5 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.6 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.1 |
1.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
0.3 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
0.5 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
0.5 |
GO:1902915 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
1.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.1 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.8 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.1 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.3 |
GO:0036071 |
N-glycan fucosylation(GO:0036071) |
| 0.1 |
1.3 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.1 |
0.1 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.1 |
1.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.1 |
GO:0010460 |
positive regulation of heart rate(GO:0010460) |
| 0.1 |
0.2 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 |
1.3 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.1 |
0.2 |
GO:0051105 |
regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.1 |
0.1 |
GO:1903516 |
base-excision repair, DNA ligation(GO:0006288) regulation of single strand break repair(GO:1903516) regulation of DNA ligase activity(GO:1904875) |
| 0.1 |
0.3 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.6 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
3.4 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.1 |
0.1 |
GO:0072011 |
macrophage colony-stimulating factor production(GO:0036301) glomerular endothelium development(GO:0072011) regulation of macrophage colony-stimulating factor production(GO:1901256) |
| 0.1 |
0.1 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
0.5 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.6 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 |
0.2 |
GO:0018023 |
peptidyl-lysine trimethylation(GO:0018023) |
| 0.1 |
0.1 |
GO:1902725 |
negative regulation of satellite cell differentiation(GO:1902725) |
| 0.1 |
0.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
0.4 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.1 |
0.1 |
GO:0086023 |
adrenergic receptor signaling pathway involved in heart process(GO:0086023) G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.1 |
0.3 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 |
0.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
0.2 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
0.4 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.2 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.1 |
GO:0009180 |
purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 |
0.3 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.1 |
0.2 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
0.6 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.5 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 |
0.4 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
1.0 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 |
0.1 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.1 |
0.2 |
GO:1903984 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.7 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.1 |
GO:0060998 |
regulation of dendritic spine development(GO:0060998) |
| 0.1 |
0.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
1.0 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.1 |
0.3 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.1 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
0.1 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.1 |
0.5 |
GO:0070424 |
regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.1 |
0.2 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.1 |
1.1 |
GO:0019221 |
cytokine-mediated signaling pathway(GO:0019221) |
| 0.1 |
0.1 |
GO:0010656 |
negative regulation of muscle cell apoptotic process(GO:0010656) |
| 0.1 |
0.3 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.1 |
0.2 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.1 |
0.1 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.3 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 |
0.1 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
0.6 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.1 |
0.1 |
GO:0061053 |
somite development(GO:0061053) |
| 0.1 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.2 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.1 |
0.4 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.1 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
1.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.3 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.1 |
0.1 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.2 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
1.2 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
2.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.1 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.3 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 |
0.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.6 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.2 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.2 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.1 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.6 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.8 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
0.4 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.5 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
| 0.1 |
0.3 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
0.1 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.4 |
GO:0038061 |
NIK/NF-kappaB signaling(GO:0038061) |
| 0.1 |
0.5 |
GO:0034398 |
telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
3.0 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.1 |
0.6 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.1 |
0.6 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.5 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.8 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
0.4 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) |
| 0.1 |
0.4 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.6 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.1 |
0.1 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 |
0.4 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
4.9 |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.1 |
0.1 |
GO:1902956 |
regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.1 |
0.1 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.4 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
2.7 |
GO:0042267 |
natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 |
0.3 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.2 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.0 |
1.1 |
GO:1901186 |
positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
0.1 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.0 |
0.4 |
GO:0048298 |
regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.5 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
1.7 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
5.5 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.7 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
1.2 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.3 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.8 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.2 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
2.2 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.0 |
0.3 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 |
0.3 |
GO:0070487 |
monocyte aggregation(GO:0070487) |
| 0.0 |
1.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.0 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.5 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
2.9 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.9 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
1.8 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.0 |
0.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.2 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.1 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.0 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
2.9 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
0.4 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.0 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.0 |
0.3 |
GO:0007549 |
dosage compensation(GO:0007549) |
| 0.0 |
0.3 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.0 |
0.4 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.0 |
0.3 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.0 |
0.3 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.0 |
0.6 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
4.2 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 |
0.3 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.0 |
1.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.3 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 |
0.0 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.0 |
0.0 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.0 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.0 |
0.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.0 |
0.1 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.0 |
GO:0072070 |
loop of Henle development(GO:0072070) |
| 0.0 |
0.4 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.3 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.3 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.0 |
0.0 |
GO:2000364 |
regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.0 |
0.2 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.6 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.0 |
0.1 |
GO:0060462 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.0 |
0.9 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
1.1 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.6 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.0 |
0.3 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.1 |
GO:0043132 |
NAD transport(GO:0043132) |
| 0.0 |
0.3 |
GO:0046782 |
regulation of viral transcription(GO:0046782) |
| 0.0 |
0.2 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.2 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.9 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.3 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.0 |
0.1 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.0 |
0.2 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.0 |
0.2 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.0 |
0.0 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.0 |
0.2 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.2 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
| 0.0 |
0.0 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.8 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.1 |
GO:0044727 |
chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 0.0 |
0.1 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.3 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.0 |
GO:0051495 |
positive regulation of cytoskeleton organization(GO:0051495) |
| 0.0 |
2.0 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
1.3 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.2 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.2 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.3 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.0 |
0.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.0 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.8 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.8 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.3 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.1 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.2 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 |
0.0 |
GO:0060359 |
response to ammonium ion(GO:0060359) |
| 0.0 |
0.1 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 |
3.9 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.2 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.0 |
0.1 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.5 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.7 |
GO:0006937 |
regulation of muscle contraction(GO:0006937) |
| 0.0 |
0.6 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.3 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.2 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.0 |
0.0 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
1.2 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.0 |
0.4 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.4 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 |
0.1 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.0 |
0.1 |
GO:0099587 |
inorganic cation import into cell(GO:0098659) inorganic ion import into cell(GO:0099587) |
| 0.0 |
0.3 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.2 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.0 |
0.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.0 |
0.2 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.1 |
GO:0072720 |
cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.0 |
0.2 |
GO:0035148 |
tube formation(GO:0035148) |
| 0.0 |
0.0 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.0 |
0.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.5 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.0 |
0.1 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.0 |
0.1 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.2 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
1.7 |
GO:0031295 |
T cell costimulation(GO:0031295) |
| 0.0 |
0.9 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.2 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.0 |
0.3 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.2 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.2 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.0 |
0.1 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 |
0.2 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 |
0.2 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.0 |
0.8 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.0 |
0.2 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 |
0.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.0 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.3 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 |
0.2 |
GO:0075713 |
establishment of integrated proviral latency(GO:0075713) |
| 0.0 |
0.3 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
1.7 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.2 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.0 |
0.1 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.0 |
0.0 |
GO:0060291 |
long-term synaptic potentiation(GO:0060291) |
| 0.0 |
0.6 |
GO:1903203 |
regulation of oxidative stress-induced neuron death(GO:1903203) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.2 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.1 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.1 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.0 |
0.1 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 |
0.0 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.2 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.1 |
GO:0061015 |
RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.0 |
0.3 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) negative regulation of cell projection organization(GO:0031345) |
| 0.0 |
2.8 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.0 |
GO:0046602 |
mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.1 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.0 |
0.1 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.0 |
0.3 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.4 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.2 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.1 |
GO:0006475 |
internal protein amino acid acetylation(GO:0006475) |
| 0.0 |
0.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.3 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.2 |
GO:0098902 |
regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.0 |
0.2 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.1 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.0 |
0.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.1 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.0 |
0.1 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.0 |
0.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.0 |
GO:1903026 |
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.0 |
0.2 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.1 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.0 |
0.1 |
GO:0019470 |
4-hydroxyproline catabolic process(GO:0019470) |
| 0.0 |
0.3 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.0 |
0.2 |
GO:0098969 |
neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.0 |
0.0 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.1 |
GO:0046851 |
negative regulation of bone remodeling(GO:0046851) |
| 0.0 |
0.1 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
0.8 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.5 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.4 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.1 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.0 |
0.2 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.2 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.8 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.0 |
0.1 |
GO:0070293 |
renal absorption(GO:0070293) |
| 0.0 |
0.1 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.0 |
0.3 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.0 |
0.4 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.1 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.0 |
0.4 |
GO:0070861 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 0.0 |
0.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.0 |
0.1 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.0 |
0.1 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.4 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.1 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.0 |
1.2 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.0 |
0.1 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.0 |
0.0 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.4 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.0 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.0 |
0.1 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.0 |
0.7 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.0 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.0 |
GO:0099525 |
presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 |
0.3 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.4 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.7 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.2 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 |
0.0 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.1 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.0 |
0.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.0 |
0.1 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.0 |
0.2 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.3 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.0 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.1 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.0 |
0.1 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.0 |
0.3 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 |
0.1 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.0 |
1.4 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.0 |
1.1 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.2 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.0 |
1.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.0 |
0.0 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.0 |
0.0 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.0 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 0.0 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0021938 |
ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.0 |
0.0 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.0 |
0.0 |
GO:1903901 |
negative regulation of viral life cycle(GO:1903901) |
| 0.0 |
0.5 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.1 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.1 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.2 |
GO:0035826 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.0 |
0.1 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.4 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.0 |
0.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.0 |
0.0 |
GO:1901419 |
regulation of vitamin D receptor signaling pathway(GO:0070562) regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.1 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.0 |
0.0 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.0 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.0 |
GO:1903747 |
regulation of establishment of protein localization to mitochondrion(GO:1903747) |
| 0.0 |
0.0 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.0 |
0.4 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.0 |
0.0 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.0 |
0.0 |
GO:1900363 |
regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 |
0.0 |
GO:0090481 |
pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.0 |
0.1 |
GO:1901185 |
negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.0 |
0.0 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.0 |
0.0 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.0 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.0 |
0.1 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.0 |
0.0 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.1 |
GO:0015684 |
ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.1 |
GO:0061037 |
negative regulation of cartilage development(GO:0061037) |
| 0.0 |
0.1 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.0 |
0.1 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.0 |
0.1 |
GO:0070173 |
regulation of enamel mineralization(GO:0070173) |
| 0.0 |
0.1 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 |
0.1 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.0 |
0.0 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 |
0.1 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.0 |
0.0 |
GO:0072331 |
signal transduction by p53 class mediator(GO:0072331) |
| 0.0 |
0.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.0 |
GO:0051664 |
nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
| 0.0 |
0.0 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.1 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.1 |
GO:0060795 |
cell fate commitment involved in formation of primary germ layer(GO:0060795) |
| 0.0 |
0.3 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 |
0.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.0 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.0 |
0.2 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.7 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.1 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.1 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.0 |
0.0 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.0 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.0 |
0.0 |
GO:0010898 |
positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.2 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.1 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.0 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.0 |
0.0 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 |
1.4 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.1 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.0 |
GO:0002551 |
mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) mast cell migration(GO:0097531) |
| 0.0 |
0.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.0 |
0.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.0 |
GO:1903555 |
regulation of tumor necrosis factor superfamily cytokine production(GO:1903555) |
| 0.0 |
0.1 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.1 |
GO:1903035 |
negative regulation of response to wounding(GO:1903035) |
| 0.0 |
0.0 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
0.0 |
GO:1903573 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
| 0.0 |
0.0 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.2 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.1 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.0 |
0.0 |
GO:0021936 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.0 |
0.0 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 |
0.1 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.0 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.0 |
0.0 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
